RCP
Rho Capital Partners Portfolio holdings
AUM
$20.4M
This Quarter Return
-13.17%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$71.6M
AUM Growth
+$71.6M
(+0.65%)
Cap. Flow
+$11.4M
Cap. Flow
% of AUM
15.96%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Mersana Therapeutics
MRSN
|
$11.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.6% |
| 2 | Technology | 0.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
1
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $54.9M | 76.67% |
3,568,057
| – | – |
|
|
2
Mersana Therapeutics
MRSN
$36.5M
| $11.4M | 15.96% |
+818,033
| New | +$11.4M |
|
3
Rocket Pharmaceuticals
RCKT
$354M
| $4.99M | 6.97% |
2,627,790
| – | – |
|
4
Senseonics Holdings
SENS
$374M
| $287K | 0.4% |
159,601
| – | – |
|